Inactive Instrument

Neighbourly Pharmacy Inc.

NBLY

CA64016L1013

Neighbourly Pharmacy Inc. Provides Preliminary Unaudited Earnings Guidance for the Second Quarter of Fiscal Year 2022

October 07, 2021 at 03:36 pm EDT

Neighbourly Pharmacy Inc. provided preliminary unaudited earnings guidance for the second quarter of fiscal year 2022. For the quarter, the company expects revenue to be approximately $90.7 million. Net Loss to be approximately $3.4 million.

Latest news about Neighbourly Pharmacy Inc.

Neighbourly Closes Take-Private Transaction with Persistence Capital Partners	Mar. 20	MT
PCP GP, L.P. completed the acquisition of remaining 49.66% stake in Neighbourly Pharmacy Inc..	Mar. 19	CI
Neighbourly Pharmacy Inc.(TSX:NBLY) dropped from S&P Global BMI Index	Mar. 14	CI
Neighbourly Pharmacy Brief: Said Overnight It Received Final Court Approval of Plan of Arrangement to be Acquired by Persistence Capital Partners	Mar. 14	MT
Neighbourly Obtains Shareholder Approval For Going Private Transaction With Persistence Capital Partners	Mar. 08	MT
Transcript : Neighbourly Pharmacy Inc. - Shareholder/Analyst Call	Mar. 08
Neighbourly Pharmacy Downgraded to Sector Perform at RBC	Feb. 14	MT
National Bank Reviews Neighbourly Pharmacy's Fiscal Q3 Results	Feb. 13	MT
Neighbourly Pharmacy's Fiscal Q3 Adjusted Profit, Revenue Climbs	Feb. 13	MT
Neighbourly Pharmacy Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 30, 2023	Feb. 13	CI
Neighbourly Pharmacy Brief: Adjusted Earnings per Share for the third quarter of $0.19, compared to $0.17 in the third quarter of 2023	Feb. 13	MT
Neighbourly Pharmacy Brief: Revenue for the third quarter increased to $284.0 million, up $18.7 million or 7.0% compared to prior year	Feb. 13	MT
Neighbourly Pharmacy Inc. Announces Executive Changes	Jan. 23	CI
Toronto Stocks Edge Forward; Neighbourly Pharmacy Rises on C$415 Million Go-Private Deal	Jan. 15	DJ
Neighbourly Pharmacy Enters into Definitive Agreement to go Private With Controlling Shareholder Persistence Capital Partners	Jan. 15	MT
BMO on Neighbourly Pharmacy's Lower Go-Private Offer	Dec. 19	MT
National Bank on Neighbourly Pharmacy's Going-private Transaction	Dec. 18	MT
Toronto Stocks Climb; Neighbourly Pharmacy Falls on Lowered Buyout Offer	Dec. 18	DJ
Neighbourly Pharmacy Providing Update on Proposal from Persistence Capital Partners	Dec. 18	MT
Neighbourly Pharmacy Brief: Persistence Capital Partners Proposing Fully Financed Offer to Take Neighbourly Private at $18.50 per Share	Dec. 18	MT
Neighbourly Pharmacy Brief: Providing Update on Proposal from Persistence Capital Partners	Dec. 18	MT
Neighbourly Pharmacy Extends 'Exclusivity' Granted to Persistence Capital Partners; Down 8.4%	Nov. 13	MT
Toronto Stocks Advance; First Quantum Slides on Curbed Operations Amid Protester Blockages in Panama	Nov. 13	DJ
Neighbourly Pharmacy Extends 'Exclusivity' Granted to Persistence Capital Partners	Nov. 13	MT
Neighbourly Pharmacy Brief: Says Committed Debt Financing Secured; Exclusivity Extended to January 15, 2024 -	Nov. 13	MT

Chart Neighbourly Pharmacy Inc.

Duration

Period

More charts

Company Profile

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy's RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company's pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.

Sector

Drug Retailers

More about the company

Sector Other Drug Retailers

	1st Jan change	Capi.
WALGREENS BOOTS ALLIANCE, INC.	-31.79%	15.36B
JD HEALTH INTERNATIONAL INC.	-36.57%	10.16B
YIFENG PHARMACY CHAIN CO., LTD.	+9.74%	6.13B
MATSUKIYOCOCOKARA & CO.	-10.81%	6.01B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-35.14%	5.65B
NAHDI MEDICAL COMPANY	-0.73%	4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+51.51%	4.33B
CLICKS GROUP LIMITED	-11.96%	3.58B
WELCIA HOLDINGS CO., LTD.	-6.33%	3.1B

Other Drug Retailers